Myofibrillar Myopathy
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
Condition snapshot
A concise guide to the condition’s pattern, detection, management and urgency.
This snapshot is a general guide, not a diagnosis or treatment plan. New, severe or worsening signs require veterinary assessment.
About the condition
Myofibrillar myopathy, or MFM, is a muscle disorder characterised by disruption of the contractile architecture and abnormal aggregates of the cytoskeletal protein desmin within scattered muscle fibres. It has been described particularly in Arabian and Warmblood horses, but presentation differs between these populations and the biology is still being defined.
Arabian endurance horses may develop painful stiffness, reluctance to continue and increased CK and AST late in a long ride or early in work after one or two weeks of rest. Warmbloods more often show vague exercise intolerance, shifting hindlimb lameness, poor impulsion and loss of muscle mass without a large rise in CK. The subtle presentation can resemble orthopaedic pain, training problems, gastric disease or saddle-related discomfort.
MFM is not interchangeable with PSSM1 or the broad commercial label “PSSM2”. PSSM1 alters glycogen handling through a recognised GYS1 mutation, whereas MFM centres on disorganisation of contractile and supporting proteins. Desmin aggregation reflects disturbed muscle architecture rather than a single established commercial genotype, and proposed inherited variants do not yet explain every affected Arabian or Warmblood.
Abnormalities involving the Z-disc and antioxidant systems have been identified, but cause, inheritance and optimal treatment are not fully settled. This uncertainty should be stated rather than covered by a generic high-fat, low-starch prescription. Some affected horses improve with carefully structured conditioning, adequate amino acids and antioxidant support, while others remain limited. Prognosis depends on discipline, severity and response to an individually monitored programme.
This disorder involves disruption and clumping of contractile proteins rather than a primary glycogen-storage mutation. Warmblood and Arabian-associated presentations are still being defined, and not every horse with desmin aggregates has the same clinical syndrome. Poor stamina, reluctance to go forward, muscle pain or atrophy can be subtle, making exclusion of lameness and training causes essential.
Screening & Early Detection
Evaluation begins with a detailed exercise pattern: duration to onset, recent rest, terrain, discipline, muscle soreness, recovery and whether performance loss occurs without enzyme elevation. CK is measured before and after a representative controlled exercise test; AST, urinalysis and electrolytes add context. Normal CK does not exclude the Warmblood presentation.
A complete lameness, back, saddle, neurologic and respiratory assessment is necessary because MFM signs are nonspecific. PSSM1 genetic testing excludes the GYS1 disorder in breeds where relevant. Definitive MFM investigation uses a biopsy from an appropriate muscle, handled and stained by a laboratory experienced in equine myopathies to identify desmin aggregates. Sampling and interpretation are most useful when clinical signs justify a management change.
Biopsy is not a routine prepurchase or breeding screen, and current commercial DNA panels do not replace it. Diet analysis includes protein quality, vitamin E, selenium and total energy without assuming deficiency. Response is tracked through repeat performance, post-exercise CK, muscle measurements and episode frequency rather than subjective improvement alone.
Treatment & Management
There is no universally proven curative treatment. Exercise is made regular and progressive, avoiding abrupt high-intensity work after prolonged rest. Arabian endurance horses require a staged return to distance with close attention to pace, terrain, hydration and recovery. Warmblood programmes emphasise gradual strengthening, correct movement and treatment of any concurrent orthopaedic or saddle problem.
The ration supplies good-quality forage and adequate high-quality protein and amino acids for muscle repair. Unlike PSSM1, strict starch restriction and a high-fat diet are not automatically required; calories, body condition and individual response determine concentrate choice. Vitamin E status is corrected when low. Antioxidant supplements such as N-acetylcysteine and coenzyme Q10 have been proposed, but evidence is evolving and they should be used with veterinary nutritional guidance rather than presented as cures.
An acute rhabdomyolysis episode receives rest, analgesia and fluids according to CK, hydration and urine findings. Long-term progress is reviewed objectively over months. Horses failing to improve need diagnostic reconsideration, not escalating unvalidated supplements. Breeding advice remains cautious because a definitive inheritance pattern and validated genetic test have not been established for MFM.
Breeds or species affected
Anglo-Arabian
Open horse breed description, care requirements and conditions
Arabian
Open horse breed description, care requirements and conditions
Shagya Arabian
Open horse breed description, care requirements and conditions
Thoroughbred
Open horse breed description, care requirements and conditions
Dutch Warmblood
Open horse breed description, care requirements and conditions
Hanoverian
Open horse breed description, care requirements and conditions
Holsteiner
Open horse breed description, care requirements and conditions
Oldenburg
Open horse breed description, care requirements and conditions
Westphalian
Open horse breed description, care requirements and conditions
Trakehner
Open horse breed description, care requirements and conditions
Selle Français
Open horse breed description, care requirements and conditions
Belgian Warmblood
Open horse breed description, care requirements and conditions
Danish Warmblood
Open horse breed description, care requirements and conditions
Swedish Warmblood
Open horse breed description, care requirements and conditions
Swiss Warmblood
Open horse breed description, care requirements and conditions
Australian Warmblood
Open horse breed description, care requirements and conditions
Irish Sport Horse
Open horse breed description, care requirements and conditions
Württemberger
Open horse breed description, care requirements and conditions
Zangersheide
Open horse breed description, care requirements and conditions